Related by context. All words. (Click for frequent words.) 70 Intermezzo ® NDA 68 Complete Response letter 66 Complete Response Letter CRL 65 PFIZER DISCLOSURE NOTICE 65 sNDA submission 64 CIP TRAMADOL ER 64 REMOXY NDA 64 Not Approvable 63 assigned PDUFA 63 PIX# trial 62 lorcaserin NDA 62 APEX AMI 62 Saforis 62 Naproxen sodium 62 Orathecin 62 novel trazodone formulation 62 granted Ortec 62 Biologic License Application BLA 62 FDA Approvable Letter 61 oxymorphone ER 61 indiplon capsules 61 sNDAs 61 Act PDUFA date 61 SPARLON 61 FDA Complete Response 61 SILENOR ™ 61 interferon gamma 1b 61 please visit http:/www.sunesis.com 61 pulls Darvon painkiller 61 http:/www.repligen.com 61 Complete Response Letter 61 BLA filing 61 ENRICH trial 60 ORAL Sync 60 FDA approvable letter 60 Barr ANDA 60 CSL Behring therapies 60 BLA submission 60 Contrave NDA 60 website www.depomed.com 60 hypersensitivity allergic reactions 60 bazedoxifene conjugated estrogens 60 telavancin NDA 60 SILENOR TM 60 ZEGERID Chewable Tablets 60 Phase III LibiGel 60 CIP ISOTRETINOIN 60 Granisetron Hydrochloride Injection 60 Complete Response 60 Nasdaq DVAX 60 PROVENGE ® 60 alogliptin NDA 60 LibiGel NDA 60 Prestara TM 59 Approvable letter 59 website www.nyandcompany.com 59 TYGACIL 59 Palatin intends 59 please visit www.advaxis.com 59 LibiGel ® testosterone gel 59 T Pred 59 PRECISE Trial 59 authority Gurian Sherman 59 preclinical pharmacokinetic 59 Marketing Approval PMA 59 DATES Comments 59 Dr. Gulfo 59 company website www.novavax.com 59 markets HP Acthar 59 supplemental biologics 59 OraTest R 59 inspectional observations 59 CORLUX CORT # 59 website http:/www.depomed.com 59 MAA submission 59 CERVARIX R 59 http:/www.cortexpharm.com 59 Inc. NASDAQ NEOL 59 testosterone gel LibiGel 59 Risperidone Oral Solution 59 Telik logo TELINTRA 59 www.adeonapharma.com 59 non nucleoside HCV 59 AIDAC 59 DISCLOSURE NOTICE 59 Biological License Application 59 adecatumumab MT# 58 website www.novavax.com 58 Linjeta TM 58 mesylate tablets approved 58 oral methylnaltrexone 58 TranSwitch indebtedness 58 Submits Response 58 Naglazyme R 58 website www.VectorGroupLtd.com 58 tramiprosate Alzhemed TM 58 severe hypercholesterolemia 58 Auxilium anticipates 58 Phase Ib study 58 subsidiaries visit http:/www.apricusbio.com 58 SILENOR 58 MEND CABG II 58 eprodisate Fibrillex TM 58 balsalazide tablet 58 Zenvia ™ 58 SPL# Gel vaginal microbicide 58 ENZON 58 nonclinical studies 58 Premarket Approval PMA 58 Buglova 58 RIGScan CR 58 ATPace TM 58 MERLIN TIMI 58 torsemide ER 58 http:/www.orexigen.com 58 serine protease inhibitor CU# 58 please visit http:/www.atherogenics.com 58 Exelbine NDA 58 website http:/www.npsp.com 58 MAGE A3 ASCI 58 approvable letters 58 lesinurad 58 SmPC 58 Nabi HB Intravenous 58 Product Monograph 58 MEND CABG 58 Company website www.nyandcompany.com 58 XL# anticancer compounds 58 Dementia Related Psychosis 58 nalbuphine ER 58 sBLA 58 PRIMO CABG 58 IV acetaminophen 58 Asentar TM 58 IGXT IntelGenx today 58 Proellex TM 58 PEARL SC 58 relapsed MCL 58 Empatic ™ 57 requiring Asthmatx 57 ANDA submission 57 Panflu TM Sinovac 57 Oracea TM 57 website www.aeroflex.com 57 http:/www.Orexigen.com 57 k Premarket Notification 57 ZEGERID Capsules 57 Dyax Biologics License Application 57 elotuzumab 57 EVLT R procedure 57 Junovan 57 bevirimat Study 57 Cariprazine 57 website http:/www.sinovac.com 57 reduce serum phosphate 57 midstage clinical 57 Prestara 57 Budesonide foam crofelemer 57 ThermoDox ® clinical 57 Kieran Downes P.Geo 57 Hematide ™ 57 developing ACAPODENE 57 Fast Track designations 57 randomized discontinuation trial 57 PRECISE trial 57 Company Prospectus dated 57 Testosterone MDTS ® 57 UVIDEM 57 Surfaxin lucinactant 57 Avantage Financial GmbH 57 DATES Written comments 57 Pruvel 57 PrevOnco ™ 57 Inc. www.micromet inc.com 57 vapreotide acetate 57 carbinoxamine 57 pivotal bioequivalence 57 Impax ANDA 57 Anidulafungin 57 L MTP PE 57 www.timhortons.com en 57 naronapride 57 HepaGam B TM 57 NEO3 57 Entereg R 57 APTIMA HPV assay 57 Dyloject TM 57 Dated announcements 57 fennel herbal teas 57 PIX# [002] 57 eprodisate KIACTA TM 57 TASKi2 57 website jabil.com 57 virus HCV protease inhibitor 57 ruxolitinib 57 www.akorn.com 57 KRYSTEXXA TM 57 Panzem R 57 NDA resubmission 57 supplemental Biologics License Application 57 Anturol TM 57 #/#/# Cytokinetics Incorporated 57 Increlex TM 57 Applehead I. 57 Nasdaq CYCC Nasdaq CYCCP 56 website www.billbarrettcorp.com 56 Pruvel ™ prulifloxacin 56 rhLF 56 Dacogen injection 56 KYNAPID 56 Peter Dimmell P.Geo 56 www.medicago.com 56 nasal calcitonin product 56 4BETTER OR WORSE 56 Biologics License Application BLA 56 alvimopan 56 XP# XP# 56 octreotide implant 56 corticotropin injection 56 Pink Sheets TAROF 56 Hedgehog antagonist 56 www.soligenix.com 56 PDX pralatrexate 56 IV RSD# 56 LibiGel Phase III 56 CRMD# 56 CAUTIONARY STATEMENT Statements 56 www.solosendoscopy.com 56 forward lookinginformation 56 novel therapeutic antibodies 56 concerning Xanthus 56 Emezine 56 trastuzumab DM1 T DM1 56 PROPEL trial 56 GLP toxicology studies 56 alvespimycin 56 NASDAQ Listing Qualification 56 pulmonology portfolio 56 Biologic License Application 56 SinuNase ™ 56 Form 8K filed 56 initiate Phase IIa 56 Marani Brands filings 56 PROSTVAC ® 56 PDUFA Date 56 www.cellgenesys.com 56 Plicera 56 hoFH 56 thispress release 56 refractory chronic lymphocytic 56 http:/www.optimerpharma.com 56 Regcourt Project 56 midstage trials 56 Silenor ® doxepin 56 torezolid phosphate 56 generic Copaxone 56 tramiprosate ALZHEMED TM 56 sitaxsentan sodium 56 www.telik.com 56 Methylphenidate Transdermal System 56 adjuvant GIST 56 http:/www.gpc-biotech.com 56 Targretin capsules 56 FACTIVE R gemifloxacin 56 Submits Biologics License Application 56 Michael Steinmann P.Geo 56 mertansine 56 See www.usa.canon.com printspeed 56 Form #Q filed 56 methylnaltrexone bromide 56 NYSE MIM MID 56 visit www.targanta.com 56 pentadentate logo R 56 Active Biotech NASDAQ OMX 56 HPV vaccine GlaxoSmithKline Cervarix 56 Resubmission 56 PLAVIX ® 56 ISO Vorin TM 56 www.BMRN.com 56 www.jnrresources.com s 56 Marketing Authorization Application 56 EMPOWER ™ 56 investigational humanized monoclonal antibody 56 malignant mesothelioma Alfacell 56 PDEIS 56 Exelixis compounds 56 oral ridaforolimus 56 dacetuzumab 56 resultsof 56 SEDAR www.SEDAR.com 56 NEBIDO 56 La.Code Crim.P. art 56 commercialize CorMedix drug 56 bazedoxifene 56 http:/www.urigen.com 56 confirmatory pivotal 56 Web Site http:/www.cryolife.com 56 Largo website www.largoresources.com 56 NeoMagic circle 56 Farfan Juan Pablo 56 Biologics License Application 56 Onrigin 56 read Palintologist 56 XL# XL# XL# XL# 56 MAb therapy 56 OvaRex ® MAb 56 TBR NYSE Amex 56 Omigard 56 Sucampo Pharmaceuticals anticipates 55 Mr. Bob Komarechka 55 phase III isavuconazole 55 Board DSMB 55 Favrille filings 55 PRIMO CABG2 55 Xcytrin R 55 octreotide acetate 55 successfully commercialize Silenor 55 Announces Tentative Approval 55 Morphine Sulfate 55 Acetavance 55 REG1 Anticoagulation System 55 Studies #CL# #CL# #CL# 55 Exelbine 55 BRIM3 55 granulated mesalamine 55 postapproval 55 Aflunov 55 AAG geldanamycin analog 55 lintuzumab SGN 55 CLIRS trial 55 Visit www.paymetric.com 55 www.delcath.com 55 incyclinide 55 Ketotransdel ® 55 Matt Pelc 55 registrational 55 Dr. Kieran Downes 55 mem. op 55 www.accentia.net 55 caustic fusion diamond 55 ONGLYZA ™ 55 initiate Phase 1b 55 approve Zenvia 55 OctoPlus licensed 55 www.goodrichpetroleum.com 55 unaudited consolidated balance sheets 55 thorough QT 55 BLOOM DM 55 www.orexigen.com 55 Marketing Authorisation Application MAA 55 TLR antagonists 55 lucinactant 55 Velac 55 Genasense ® oblimersen 55 liver resection surgeries 55 initiate multicenter 55 Submits NDA 55 TSX DMM Dynasty 55 Premarket Approval Application 55 reflect Medicago 55 please visit www.lexpharma.com 55 IONSYS TM 55 dimebon latrepirdine 55 www.vioquestpharm.com 55 rALLy trial 55 National Coverage Determination 55 i2 expressly disclaims 55 successfully commercialize Iluvien 55 Exforge HCT 55 Approvable Letter 55 GeoVax AIDS vaccine 55 Application MAA 55 Clinical Trials Update 55 Phase lll 55 omeprazole widely 55 Please visit http:/www.ti.com/wirelesspressroom 55 Adenuric R 55 non constipation irritable 55 Aurora kinase inhibitor 55 molecular imaging radiopharmaceuticals 55 Emezine R 55 fusion enhancers 55 Mr. Karbe 55 spokeswoman Lenore Gelb 55 e mail lifestyle@readingeagle.com 55 Pre IND 55 #CL# 55 www.iconplc.com 55 Genta Incorporated OTCBB 55 FOLOTYN ® 55 website aStockMarketLife.com 55 website www.swwc.com 55 FACTIVE tablets 55 randomized controlled multicenter 55 www.emergentbiosolutions.com 55 sporicidal product 55 ENABLE Phase 2 55 adulterated peanuts 55 Nasdaq ONXX today 55 REVIVE TA 55 APF# NDA 55 Fibrillex TM 55 Romiplostim 55 vii Cubist ability 55 R sipuleucel T 55 LymphoStat B belimumab 55 regardingthe 55 BRILINTA 55 Stephanie Kwisnek spokeswoman 55 Amoxicillin PULSYS Phase III 55 Submits IND 55 Bionutrics 55 Zolpimist 55 AcryMed Incorporated 55 Sanctura XR 55 visit biotech.com 55 developing ostarine selective 55 Stimuvax R 55 GTC recombinant form 55 Company website www.nashfinch.com 55 www.idgenterprise.com 55 LUNESTA TM 55 www.rda.com 55 R rosiglitazone maleate 55 NASDAQ Hearings Panel 55 Hereafter Inception Iron Man 55 PREOS 55 Agria filings 55 Sumatriptan Succinate Tablets 55 iloperidone 55 PREOS R 55 AVERROES 55 IIa trial 55 Board MVEIRB 55 please visit www.inhibitex.com 55 LOCs unless 55 non nucleoside inhibitor 55 Zemplar Capsules 55 cladribine tablets 55 www.micromet inc.com 55 APEX AMI trial 54 CONBRIZA 54 #D#C# 54 includes TOLAMBA TM 54 please visit www.medicinova.com 54 Triapine R 54 NASDAQ GNTA 54 please visit http:/www.biogenidec.com 54 AMPAKINE CX# 54 SAR# [004] 54 budesonide foam 54 albiglutide 54 See www.claymore.com CEF 54 Tarceva TM 54 evaluating bafetinib 54 DPX Survivac 54 Primera Bioscience 54 Sepracor anticipates 54 http:/www.wendys-invest.com/safeharbor 54 AD docket 54 http:/www.camtek.co.il 54 Marketing Authorization Applications 54 Aloxi Injection 54 http:/www.tripos.com 54 http:/www.lecroy.com 54 Consent Revocation Statement 54 Zolpidem Tartrate Tablets 54 Phase IIb III 54 Arzerra ofatumumab 54 pharmacodynamic markers 54 European Medicines Evaluation 54 TJ Termuende P.Geo 54 ELADUR 54 ZEGERID Powder 54 pralatrexate 54 alemtuzumab MS 54 LEP ETU 54 Frova ® 54 http:/www.solerainc.com 54 LPM TM 54 TRIOLEX HE# APOPTONE HE# 54 * Potentially libelous 54 Psychopharmacologic Drugs Advisory 54 Phenoptin 54 novel emulsion formulation 54 Zarghun Shah district 54 flammable aromatic oils 54 Entocort 54 Idenix anticipates 54 Through Glycoscience R 54 GoFish periodic filings 54 AVADO 54 OFIRMEV 54 Exocrine Pancreatic Insufficiency 54 proprietary Capillary Aerosolization Technology 54 TLR Timberline 54 rheumatoid arthritis osteoarthritis ankylosing 54 Keppra ® XR 54 Farmstead Telephone 54 ULTRASE 54 Cerberus ABP Investor 54 Natus disclaims 54 visit www.parpharm.com 54 MacroChem Corporation 54 Sular formulation 54 Stavzor 54 proprietary transdermal patch 54 TBC# 54 Telavancin 54 pralatrexate injection folate analogue 54 dacetuzumab collaboration 54 Hiberix 54 TOLAMBA 54 web site http:/www.gtc-bio.com 54 autologous cellular immunotherapy 54 Pharming website http:/www.pharming.com 54 Acurox r Tablets 54 www.bphx.com 54 SURFAXIN 54 Premarket Approval 54 Orapred ODT 54 PennyStockBets.com employees 54 Tiffaney Utsman senior 54 RANK Ligand inhibitor 54 HyQ 54 David Gower P.Geo 54 Entereg TM 54 QAQC protocol 54 sNDA 54 BOS periodic 54 Acetavance TM 54 KRYSTEXXA TM pegloticase 54 EXPLORE Xa 54 Renvela ® 54 BEMA TM LA 54 TASKi3 54 Hematide ™ peginesatide 54 www.cytomedix.com 54 Xenazine ® 54 K ras mutations 54 HGS ETR2 54 unblind 54 Timothy Froude P. Geo 54 Anturol ® 54 ongoing Phase IIIb 54 mesylate tablets 54 worsening thrombocytopenia 54 Company website www.jcrew.com 54 MAXY alpha 54 DJ AIGCI Handbook 54 arsenic trioxide injection 54 NDA submission 54 Vitaxin 54 SWX BSLN 54 lexidronam injection 54 IND Investigational New 54 Corrects typographical error 54 www.dctindustrial.com 54 efalizumab 54 Mylan ANDA 54 gave Makena orphan 54 Oral Calcitonin 54 vitro dissolution 54 Prostate AdenoCarcinoma Treatment 54 involve risksand uncertainties 54 www.hochtief.com press 54 Erik Ostensoe P. Geo 54 APNB 54 faropenem medoxomil 54 CD# CEA 54 carcinogenicity studies 54 NASDAQ BDSI 54 Company website www.gcgaming.com 54 SYCREST 54 oral prodrug 54 pediatric exclusivity 54 Somaxon cautions readers 54 Cynosure anticipates 54 diagnostic radiopharmaceutical 54 phase Ib 54 Geac intentions 54 Valeant unsolicited 54 MK #B 54 designated cethromycin 54 Receives Approvable Letter 54 website www.encana.com 54 Mark Baknes P. Geo 54 acronym INA 54 Aurexis 54 evaluating intravenous picoplatin 54 apoptosis inducer 54 http:/www.nabi.com 54 containing LABAs 54 OR INFORMATION INVOLVE 54 novel bactericidal 54 vismodegib 54 ARIKACE ™ 54 reflect Ronn Motors 54 pixantrone NDA 54 ER oxymorphone hydrochloride 54 Kosan dependence 54 http:/www.lemaitre.com 54 Market Authorization Application 54 EDEMA4 trial 54 RSD# oral 54 website www.daveandbusters.com 54 Levulan ® PDT 54 By Justin Berka 54 site http:/www.integrabank.com 54 Quinton Hennigh Ph.D. P.Geo 54 Kynapid 54 NYSE Amex PTN 54 pantoprazole sodium 54 Jim Romenesko Published 54 EVIZON TM squalamine lactate 54 Marketing Authorisation Application 54 STATEMENT Statements 54 OMAPRO ™ 54 Salary.com expressly disclaims 54 Dhou declined 54 programs visit http:/www.dendreon.com/ 54 Daytrana TM 54 Gabriel Mollet 54 NYSE Amex KRY 54 AcryMed technologies 54 PLK1 SNALP 54 website www.orvana.com 54 ZOLINZA 53 Lipid Sciences assumes 53 Files Investigational 53 BYDUREON 53 CDP# 53 Nanometrics disclaims 53 desvenlafaxine 53 Theforward looking 53 Shigamabs 53 targeted molecular radiotherapeutics 53 Lauren Silvernail 53 agent Jennifer Leyn 53 NicVAX TM 53 By Malcolm Maclachlan 53 Application BLA 53 CEL SCI Phase III 53 TWYNSTA 53 Dr. Giles Peatfield 53 enzastaurin 53 laromustine 53 GRAS notification 53 MVLWB 53 recombinant PSMA vaccine 53 galiximab 53 please visit www.sra.com 53 Globicus coincident index 53 vinflunine 53 IND submission 53 YOUR LOCAL ANIMAL SHELTER 53 opioid induced bowel dysfunction 53 Biophan patent 53 GATTEX TM 53 newsrelease 53 Completes Patient Enrollment 53 GATTEX ™ 53 novel VDA molecule 53 formal pharmacokinetic PK 53 Poly ICLC 53 Plenaxis R 53 recurrent metastatic ovarian cancer 53 Amoxicillin PULSYS 53 Alzhemed TM 53 huC# DM4 53 depressive episodes associated 53 EMBEDA ™ 53 Barry Devlin M.Sc. 53 postoperative ileus POI 53 1bdrm Apartment washer dryer 53 risksand uncertainties 53 beaded fringed belt 53 ACIP recommendations 53 TransVax 53 Asentar 53 Ranexa R 53 NUVIGIL 53 DAILY LARIAT ONE 53 NxStage anticipates 53 phase IIb study 53 www.chesapeakelodgingtrust.com 53 patriotism Gration 53 please visit http:/www.toshiba.com/taec/ 53 Somatuline R Autogel R 53 R brand eszopiclone 53 xxxi adverse tax 53 GTC recombinant human 53 Phase IIa clinical trials 53 BY MAKING THESE 53 By EURSOC Two 53 ENGINEERING.com Incorporated Announces 53 hydrochloric acid nitric acid 53 website www.diamyd.com 53 Allovectin 7 ® 53 vivian manning posted 53 SYMMETRY trial 53 sarcoma melanoma 53 Inc. Nasdaq SEPR 53 faropenem 53 Fanapt ™ 53 Airvana anticipates 53 trastuzumab emtansine T DM1 53 within themeaning 53 candidate SILENOR TM 53 DIFICID ™ 53 b.cektir @ todayszaman.com 53 www.uct.com 53 Zeb Horowitz 53 rPA vaccine candidate 53 asthma immunotherapeutic 53 IgG1 monoclonal antibody 53 2 inhibitor CYT# 53 BY JOHN SMYNTEK 53 GALNS 53 compound INCB# 53 Lenocta TM 53 LEVAQUIN ® 53 www.durect.com 53 targeting refractory relapsing 53 Pirfenidone 53 BEMA ® 53 Pharmacokinetic parameters 53 Product Characteristics 53 Marketing Authorisation Holders 53 Known hypersensitivity 53 SUCCEED trial 53 D. Medicals 53 PNP inhibitor 53 TAXUS Element Stent System 53 MacroChem actual 53 bepotastine besilate nasal spray 53 verbatim extract 53 REVIVE Diabetes 53 R# #mg BID 53 sorafenib tablets 53 Final Appraisal Determination 53 Gel repository corticotropin injection 53 reflect GuestLogix 53 Triage Stroke Panel 53 INVEGA ® 53 DePace vast 53 Flutiform ™ 53 may visit adviserinfo.sec.gov 53 Cogent IR 53 Zemiva TM 53 coronary stent merged 53 www.ferro.com 53 TELINTRA 53 www.kla tencor.com 53 GRALISE 53 Orvana website www.orvana.com 53 Biovail undertakes 53 confirmatory clinical 53 www.kriaresources.com 53 R lenalidomide 53 Centralized Procedure 53 Mike Magrum P.Eng 53 propoxyphene containing 53 treat chronic sinusitis 53 tanespimycin 53 Emily Blunt shimmered 53 TRIOLEX ™ 53 PROVIGIL 53 initiate Phase IIb 53 Giselle Bautista 53 visiting CDW.com 53 Halotron revenues 53 Full Prescribing Information 53 SUTENT ® 53 FavId 53 Markland Technologies filings 53 Archived webcasts 53 TWYNSTA ® 53 Giants Kiick 53 endoscopic gastric ulcers 53 HTA periodic 53 Auxilium assessments 53 genotoxicity studies 53 injectable formulations 53 biostatistical analysis 53 website www.loews.com 53 EvaMist TM 53 financialstatements 53 approvable letter 53 Dr. Scangos 53 Inc. Nasdaq TELK 53 Zerenex Phase 53 bicifadine 53 www.amvescap.com 53 PURPOSE OF SAFE HARBOR 53 LEVADEX ™ 53 Vectibix panitumumab 53 sue# 53 Amex PTN 53 PRAGUE Komercni Banka 53 mifamurtide 53 FDA Accepts 53 CEFF financings subject 53 Vernakalant 53 www.visioneer.com/# 53 Yucheng filings 53 Mr. Amireault 53 website http:/www.adolor.com 53 BCX# 53 Phase 2b kidney transplant 53 By RohitSharma TennisEarth.com 53 boxed WARNING 53 David Bending M.Sc. 53 Phase Ib II 53 Metformin HCl 53 Nasdaq OPTR 53 theglobe.com inc 53 accompanying electrolyte abnormalities 53 Phase 1a clinical 53 Valtropin 53 Vectical TM Ointment 53 forodesine 53 Octreolin 53 Horizant 53 www.repligen.com 53 ie antibody mediated 53 vivo toxicology 53 AudioCodes filings 53 commercialize toremifene 53 www.Navistar.com newsroom 53 EOquin 53 Hexvix ® 53 Spokesman Brian Roehrkasse 53 CoFactor 53 ENESTnd Evaluating Nilotinib Efficacy 53 teduglutide 53 PMA submission 53 PANVAC VF 53 Visit www.pingidentity.com 53 CHMP opinion 53 ENL recurrence 53 By Jeff Smykil 53 QNEXA 53 Marketing Authorization Application MAA 53 Amigal TM 53 anyforward looking 53 application sNDA 53 visit www.cyclacel.com 53 VanceInfo filings 53 PDE4 inhibitor 53 MattM 53 PSMA ADC 53 journal Gynecologic Oncology 53 iclaprim 53 IL# PE#QQR 53 http:/www.clearwire.com 53 visit www.novabaypharma.com 53 Crisa acquisition 53 Subpart E 53 www.AccessNationalBank.com 53 visit www.intellon.com 53 ASCO Gastrointestinal Cancers Symposium 53 theseforward looking 53 Vitrasert R 53 Keith McKey 53 4C Controls undertakes 53 Urocidin TM 53 casopitant 53 Tinta Zone 53 neratinib 52 tolevamer 52 JOULFERON 52 liprotamase 52 MyVax R 52 Lilly Evista 52 omeprazole sodium bicarbonate 52 ANCHOR trial 52 www.atsc.com 52 ONTAK 52 riociguat 52 Ostarine TM 52 www.northfieldlabs.com 52 TELCYTA 52 ocular formulation 52 Citizen Petition 52 EvaMist NDA submission 52 Combidex 52 KNS # 52 Rivard MJ 52 TP# CETi 1 52 Staphylococcus aureus Immune Globulin 52 www.siemens.com energy 52 Incorporated Nasdaq KOSN 52 EFFECTIVE DATE 52 Michael P. Rosatelli 52 proprietary intravenous formulation 52 Competitor Reports provide 52 Magma undertakes 52 CHMP recommendation 52 ISTODAX 52 Nasdaq Listing Qualification 52 SEC Regulation SX 52 Draft EIR 52 Dojack faces 52 Natus disclaims any 52 pegloticase 52 Raptiva R 52 Lancet Neurology journal 52 suchstatements 52 leading oral taxane 52 Liprotamase 52 Ravelston Entities 52 filingswith 52 Firazyr 52 Ofirmev 52 PLAVIX R clopidogrel bisulfate 52 dalbavancin 52 OraTest 52 methylnaltrexone 52 www.royalcaribbean.com www.celebrity.com www.pullmAhmed Hilles clan 52 inhaled AAT 52 miconazole Lauriad R 52 anything Chachoute 52 tiapamil 52 Intellon assumes 52 footnotes thereto 52 XOMA 3AB 52 Please visit www.glglifetech.com 52 ezogabine 52 Topical Interferon Alpha 2b 52 Teasing caresses 52 Alfa Laval AB publ 52 orBec ® oral beclomethasone 52 sBLA filings 52 Achillion anticipates 52 EXPECTED RESULTS MAY INCLUDE 52 Visit www.einsteinnoah.com 52 Rotarix ® 52 Supplemental Biologics License Application 52 www.nac tsx.com 52 information visit www.Joann.com 52 CapitalBank locations 52 file INDs 52 Spokeswoman Lori Fligge 52 services visit www.networkengines.com 52 CoTherix logo 52 CancerVax Corporation 52 Marketing Authorisation 52 5 HT2A inverse 52 Nicotine Conjugate Vaccine 52 Presentation Slides Printable slides 52 Explor Resources inc 52 http:/www.mpegla.com 52 www.royalcaribbean.com www.celebrity.com 52 carbohydrate polymers 52 visit http:/www.chinawindsystems.com 52 Tom Le Veque 52 Eschelon Telecom undertakes 52 PS# DARA 52 R sorafenib tablets 52 PEG PAL 52 GALE STREET INN 52 http:/www.nyseeuronext.com/ir 52 PEG SN# 52 Centerplate undertakes 52 Osteologix undertakes 52 Iloperidone 52 VERTEX PHARMACEUTICALS 52 reflect Ronn Motor 52 Mr. Bernard Boily 52 TSX VENTURE PEF 52 information visit www.parpharm.com 52 zileuton CR 52 Graniz Loan 52 investigational hepatitis B 52 By JENNIFER RADCLIFFE 52 cinacalcet HCl 52 business@scni.com 52 s pill Qnexa 52 alogliptin 52 SinuNase TM 52 see www.virexx.com 52 explanatory memoranda 52 ACAPODENE TM 52 services visit www.nirvanix.com 52 Orosi Mill project 52 Angiox ® 52 Dr. Manuso 52 lumiliximab 52 AVN# Phase 52 LibiGel ® 52 TomoTherapy judgments 52 CRHI 52 androgen receptor modulator 52 Genz # 52 www.norsat.com 52 TSX VENTURE FWR 52 subsequent amendments thereto 52 Initiates Enrollment